On April 15, 2025, President Trump signed an executive order titled “Lowering Drug Prices by Once Again Putting Americans First.” The order includes various provisions that are relevant to the pharmaceutical industry,...more
4/22/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Executive Orders ,
Inflation Reduction Act (IRA) ,
Life Sciences ,
Medicare ,
Pharmaceutical Industry ,
Prescription Drugs ,
Proposed Legislation ,
Regulatory Reform ,
Tariffs ,
Trump Administration
The proposed cuts would place a 15% indirect cost rate on all new and existing grant awards received by research institutions and universities....more
3/5/2025
/ Colleges ,
Department of Health and Human Services (HHS) ,
Executive Orders ,
Federal Funding ,
Federal Grants ,
Government Agencies ,
Grants ,
Life Sciences ,
Medical Research ,
National Institute of Health (NIH) ,
Preliminary Injunctions ,
State and Local Government ,
Trump Administration ,
Universities
Navigating the Trump administration executive order impacting pediatric gender dysphoria evidence, coverage, disclosures, regulation, legislation, and enforcement as well as grants to certain medical institutions, including...more
The proposed cuts would place a 15% indirect cost rate on all new and existing grant awards received by research institutions and universities....more
2/14/2025
/ Colleges ,
Department of Health and Human Services (HHS) ,
Executive Orders ,
Federal Funding ,
Federal Grants ,
Medical Research ,
National Institute of Health (NIH) ,
Pending Litigation ,
Regulatory Agenda ,
Research Funding ,
Scientific Research ,
State Attorneys General ,
Trump Administration ,
Universities
Navigating the Trump administration executive order impacting pediatric gender dysphoria evidence, coverage, disclosures, regulation, legislation, and enforcement as well as grants to certain medical institutions, including...more